Team:Tufts

From 2014.igem.org

(Difference between revisions)
Line 69: Line 69:
<td width="30px"></td>
<td width="30px"></td>
<td align="left">
<td align="left">
-
This year, we are competing in the International Genetically Engineered Machine (iGEM) Competition
+
<!--This year, we are competing in the International Genetically Engineered Machine (iGEM) Competition
with a project which uses a bacteriophage to block the formation of biofilms. We have received a grant  
with a project which uses a bacteriophage to block the formation of biofilms. We have received a grant  
Line 90: Line 90:
<br><br>
<br><br>
   
   
-
 
The conference, titled The Future of Phage and Synthetic Biology, incorporates two events. The first a  
The conference, titled The Future of Phage and Synthetic Biology, incorporates two events. The first a  
Line 108: Line 107:
orally by Penn Schoen Berland (PSB) Research and online through Tufts Qualtrics.
orally by Penn Schoen Berland (PSB) Research and online through Tufts Qualtrics.
 +
-->
 +
Robust biofilm formation using a cyclic-di-GMP aptamer and investigating ethics and applications of engineered bactiophage
 +
A long, noncoding massively expressed regulatory RNA (merRNA) discovered in Bdellovibrio bacteriovorus is present in high levels during its dormant phase. The merRNA is believed to sequester cyclic-di-GMP, much like a sponge. Since cyclic-di-GMP is a second messenger for various cellular functions, including motility and biofilm formation, the Tufts iGEM team introduced this merRNA sequence into E. coli. Constitutive expression of this merRNA transcript was shown to increase biofilm formation. This property can be useful in microbe-based approaches to environmental remediation. Earlier designs for phage delivery of the merRNA to disrupt biofilms inspired an investigation into the policy surrounding engineered bacteriophage. Tufts iGEM will be convening a panel of experts from various disciplines to put forth recommendations for the responsible use of phage in therapeutic and industrial applications. A proposal will be drafted for a silk bandage containing a phage cocktail which can prevent and treat infection by antibiotic-resistant bacteria.
</td>
</td>
<td width="35px"></td>
<td width="35px"></td>

Revision as of 17:51, 17 September 2014

Tufts iGEM 2014

Home Team Official Team Profile Project Parts Modeling Notebook Safety Attributions
Robust biofilm formation using a cyclic-di-GMP aptamer and investigating ethics and applications of engineered bactiophage A long, noncoding massively expressed regulatory RNA (merRNA) discovered in Bdellovibrio bacteriovorus is present in high levels during its dormant phase. The merRNA is believed to sequester cyclic-di-GMP, much like a sponge. Since cyclic-di-GMP is a second messenger for various cellular functions, including motility and biofilm formation, the Tufts iGEM team introduced this merRNA sequence into E. coli. Constitutive expression of this merRNA transcript was shown to increase biofilm formation. This property can be useful in microbe-based approaches to environmental remediation. Earlier designs for phage delivery of the merRNA to disrupt biofilms inspired an investigation into the policy surrounding engineered bacteriophage. Tufts iGEM will be convening a panel of experts from various disciplines to put forth recommendations for the responsible use of phage in therapeutic and industrial applications. A proposal will be drafted for a silk bandage containing a phage cocktail which can prevent and treat infection by antibiotic-resistant bacteria.